National Institute of Neurological Disorders and Stroke; Notice of Meetings, 28829 [E8-11089]

Download as PDF Federal Register / Vol. 73, No. 97 / Monday, May 19, 2008 / Notices the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group, Microbiology and Infectious Diseases Research. Committee Date: June 12, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Allerton Hotel, 701 N. Michigan Avenue, The Venetian Room, 23rd Floor, Chicago, IL 60611. Contact Person: Annie Walker-Abbey, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, Rm. 3126, Bethesda, MD 20892–7616, 301– 451–2671, aabbey@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the National Advisory Neurological Disorders and Stroke Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: May 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–10949 Filed 5–16–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Amended Notice of Meeting pwalker on PROD1PC71 with NOTICES Notice is hereby given of a change in the meeting of the National Advisory Mental Health Council, May 22, 2008, 10:30 a.m. to May 23, 2008, 12:30 p.m., National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892 which was published in the Federal Register on April 23, 2008, 73FR21967. The Closed Grant Review session of the National Advisory Mental Health Council will start at 11 a.m. instead of 10:30 a.m. This Closed session on May 22, 2008, will be at the Neuroscience Center, 6001 Executive Boulevard, Rockville, MD. The meeting is partially Closed to the public. Dated: May 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11087 Filed 5–16–08; 8:45 am] BILLING CODE 4140–01–M VerDate Aug<31>2005 17:18 May 16, 2008 Jkt 214001 National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meetings Name of Committee: National Advisory Neurological Disorders and Stroke, Council Clinical Trials Subcommittee. Date: May 29, 2008. Closed: 8 a.m. to 9 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, C Wing, Conference Room 10, Bethesda, MD 20892. Open: 9 a.m. to 10 a.m. Agenda: To discuss clinical trials policy. Place: National Institutes of Health, Building 31, 31 Center Drive, C Wing, Conference Room 10, Bethesda, MD 20892. Contact Person: Deborah G Hirtz, MD, Acting Director, Clinical Trials Cluster, National Institute of Neurological Disorders and Stroke, National Institute of Health, 6001 Executive Blvd., Suite 2212, Bethesda, MD 20892, (301) 496–5821, hirtz@ninds.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Advisory Neurological Disorders and Stroke Council Basic and Preclinical Programs Subcommittee. Date: May 29, 2008. Closed: 8 a.m. to 8:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, C Wing, Conference Room 7, Bethesda, MD 20892. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 28829 Open: 8:30 a.m. to 10 a.m. Agenda: To discuss basic and preclinical programs policy. Place: National Institutes of Health, Building 31, 31 Center Drive, C Wing, Conference Room 7, Bethesda, MD 20892. Contact Person: Jill E. Heemskerk, PhD, Acting Chief, Technology Development, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Boulevard, Suite 2229, MSC 9527, Bethesda, MD 20892–9527, (301) 496– 1779, jh440o@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Information is also available on the Institute’s/Center’s home page: https:// www.ninds.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: May 12, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11089 Filed 5–16–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; ZAA1 CC–12 Member Conflict. Date: June 26–27, 2008. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Legacy Hotel, 1775 Rockville Pike, Rockville, MD 20852. E:\FR\FM\19MYN1.SGM 19MYN1

Agencies

[Federal Register Volume 73, Number 97 (Monday, May 19, 2008)]
[Notices]
[Page 28829]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11089]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of 
the National Advisory Neurological Disorders and Stroke Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke, Council Clinical Trials Subcommittee.
    Date: May 29, 2008.
    Closed: 8 a.m. to 9 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
    Open: 9 a.m. to 10 a.m.
    Agenda: To discuss clinical trials policy.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C Wing, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Deborah G Hirtz, MD, Acting Director, Clinical 
Trials Cluster, National Institute of Neurological Disorders and 
Stroke, National Institute of Health, 6001 Executive Blvd., Suite 
2212, Bethesda, MD 20892, (301) 496-5821, hirtz@ninds.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council Basic and Preclinical Programs Subcommittee.
    Date: May 29, 2008.
    Closed: 8 a.m. to 8:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C Wing, Conference Room 7, Bethesda, MD 20892.
    Open: 8:30 a.m. to 10 a.m.
    Agenda: To discuss basic and preclinical programs policy.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C Wing, Conference Room 7, Bethesda, MD 20892.
    Contact Person: Jill E. Heemskerk, PhD, Acting Chief, Technology 
Development, National Institute of Neurological Disorders and 
Stroke, National Institutes of Health, 6001 Executive Boulevard, 
Suite 2229, MSC 9527, Bethesda, MD 20892-9527, (301) 496-1779, 
jh440o@nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Information is also available on the Institute's/Center's home 
page: https://www.ninds.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: May 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-11089 Filed 5-16-08; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.